节点文献

非那雄胺片在健康人体内的药动学及生物等效性研究

Pharmacokinetics and Bioequivalence of Finasteride Tablets in Healthy Subjects

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 黄鑫丁黎沈建平简龙海张正行张银娣

【Author】 HUANG Xin 1,DING Li 1,SHENG Jian-Ping 2 ,JIAN Long-Hai 1,ZHANG Zheng-Xing 1,ZHANG Yin-Di 2 1 Department of Pharmaceutical Analysis,China Pharmace utical University,Nanjing 210009; 2 Clinical Pharmacology Institute,Nanjing Medical Universiy,Nanjing 2 10029,China

【机构】 中国药科大学药物分析学教研室南京医科大学临床药理研究所南京医科大学临床药理研究所 南京210009南京210009南京210029南京210029

【摘要】 目的 :建立人血浆中非那雄胺的HPLC ESI MS测定法 ,以测定志愿者口服非那雄胺片剂 (5mg/片 )后的血药浓度 ,并对受试制剂和参比制剂的生物等效性进行评价。方法 :血浆样品以 0 1mol/L的NaOH碱化后用乙酸乙酯提取 ,进行HPLC ESI MS分析 ,色谱柱为LichrospherC18(5μm ,2 5cm× 4 6mm ) ,流动相为甲醇 10 0 μmol/L醋酸钠水溶液 (86∶14 ) ,内标为醋酸甲羟孕酮 ,检测离子为m/z 3 95(非那雄胺 )、m/z 40 9(内标 ) ,裂解电压为 10 0V。 2 0名健康志愿者交叉口服供试片和参比片 ,剂量均为 5mg。计算主要药动学参数及相对生物利用度 ,以判断生物等效性。结果 :在 0 1~ 2 0 0ng/ml范围内非那雄胺与内标峰面积比值与浓度线性关系良好 ,最低定量限为 0 0 5ng/ml。受试制剂及参比制剂的生物半衰期分别为 4 6± 1 2h和 4 4± 1 1h ,达峰时间分别为3 1± 0 9h和 2 8± 1 2h ,峰浓度分别为 59 4± 17 9ng·ml-1 和 63 6± 2 2 9ng·ml-1 。以AUC0 2 4计算的受试制剂的相对生物利用度为 (96 9± 14 6) %。结论 :本实验建立的分析方法灵敏、准确、简便。统计学结果表明两种制剂生物等效。

【Abstract】 AIM:To develop a HPLC-ESI-MS assay for det ermination of finasteride in human plasma and to investigate the pharmacokinetic s and bioequivalence of finasteride tablets(testing tablets and reference table ts) in human. METHOD: After being made alkaline with sodium hydroxide,plasma was extracted with ethy l acetate and separated by HPLC on a reversed-phase C 18 column with a mobil e ph ase of 100 μmol/L ammonium sodium water solution-methanol (16∶84,v/v). L C-ES I MS was performed in the selected ion monitoring (SIM) mode using target ions a t m/z 395 for finasteride and m/z 409 for the internal standard. The fragmental voltage was 100 V. A randomized crossover design was performed in 20 healthy vol u nteers In the study periods,a single 5 mg dose of each tablet was admini st ered to each volunteer RESULT:Calibration curves were linear ov e r the range 0 1~200 ng/ml The limit of quantification for finasteride in pla sma was 0 05 ng/ml The main pharmacokinetic parameters t 1/2 ,t max and c max were 4 6±1 2 h,3 1±0 9 h and 59 4 ± 17 9 ng/ml for the reference tabl et; 4 4±1 1 h,2 8±1 2 h and 63 6±22 9 ng/ml for the test t ablet respective ly The relative bioavalability of the reference tablet was (96 9±14 6)% T he resu lts of variance analysis and two one-sided t-test showed that there was no sign ificant difference between the two formulations in the AUC and c max .CONCLUSION:The assay was proved to be sensitive,accurate and convenient The two formulations were bioequivalent

  • 【文献出处】 中国药科大学学报 ,Journal of China Pharmaceutical University , 编辑部邮箱 ,2003年06期
  • 【分类号】R96
  • 【被引频次】4
  • 【下载频次】248
节点文献中: 

本文链接的文献网络图示:

本文的引文网络